On ECHEMI
Home > Drugs > HOMATROPINE METHYL BROMIDE Registered Holders
HOMATROPINE METHYL BROMIDE structure

HOMATROPINE METHYL BROMIDE structure

HOMATROPINE METHYL BROMIDE

Homatropine Methylbromide is muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 170.3 nM, respectively.target: mAChRIC 50: WKY-E(162.5 nM), SHR-E(170.4nM )In vitro: Homatropine (20 μM) alone produces a dose ratio of 259 in atrium from guinea-pigs. Homatropine (20 μM) produces a dose ratio of only 95.0 when combined with hexamethonium in atrium from guinea-pigs.In vivo: : Pre-treatment with homatropine (20 m

Find 4 Related Holders

HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
C-SQUARED PHARMA LIMITED
European Union European Union

API Registration Country

API Active
BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG
United States United States

API Registration Country

API Inactive
Boehringer Ingelheim Pharma GmbH & Co. KG
European Union European Union

API Registration Country

API Inactive
Recommended Suppliers of HOMATROPINE METHYL BROMIDE
View 7 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.